SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-01-000959
Filing Date
2001-03-28
Accepted
2001-03-28 00:00:00
Documents
5
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. b38126ane10-k.txt 10-K 258880
2 SUBSIDIARIES OF THE COMPANY b38126anex21-1.txt EX-21.1 278
3 CONSENT OF KPMG LLP b38126anex23-1.txt EX-23.1 1027
4 POWER OF ATTORNEY b38126anex24-1.txt EX-24.1 2329
5 IMPORTANT FACTORS RE FORWARD LOOKING STATEMENTS b38126anex99-1.txt EX-99.1 44156
  Complete submission text file 0000950135-01-000959.txt   308665
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29089 | Film No.: 1581713
SIC: 2836 Biological Products, (No Diagnostic Substances)